DE69522689D1 - Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper - Google Patents

Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper

Info

Publication number
DE69522689D1
DE69522689D1 DE69522689T DE69522689T DE69522689D1 DE 69522689 D1 DE69522689 D1 DE 69522689D1 DE 69522689 T DE69522689 T DE 69522689T DE 69522689 T DE69522689 T DE 69522689T DE 69522689 D1 DE69522689 D1 DE 69522689D1
Authority
DE
Germany
Prior art keywords
glioma
cell cycle
monoclonal antibodies
human monoclonal
independent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69522689T
Other languages
English (en)
Other versions
DE69522689T2 (de
Inventor
Biotech Inc Toronto Viventia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viventia Bio Inc
Original Assignee
Viventia Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viventia Biotech Inc filed Critical Viventia Biotech Inc
Publication of DE69522689D1 publication Critical patent/DE69522689D1/de
Application granted granted Critical
Publication of DE69522689T2 publication Critical patent/DE69522689T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69522689T 1994-06-21 1995-06-16 Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper Expired - Fee Related DE69522689T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/264,093 US5639863A (en) 1994-06-21 1994-06-21 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
PCT/CA1995/000361 WO1995035374A1 (en) 1994-06-21 1995-06-16 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen

Publications (2)

Publication Number Publication Date
DE69522689D1 true DE69522689D1 (de) 2001-10-18
DE69522689T2 DE69522689T2 (de) 2002-08-08

Family

ID=23004543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69522689T Expired - Fee Related DE69522689T2 (de) 1994-06-21 1995-06-16 Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper

Country Status (12)

Country Link
US (1) US5639863A (de)
EP (1) EP0766736B1 (de)
JP (1) JPH10501411A (de)
CN (1) CN1074458C (de)
AT (1) ATE205532T1 (de)
AU (1) AU686394B2 (de)
CA (1) CA2192079C (de)
DE (1) DE69522689T2 (de)
MX (1) MX9605895A (de)
NO (1) NO965395L (de)
NZ (1) NZ288157A (de)
WO (1) WO1995035374A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4124486B2 (ja) 1996-05-22 2008-07-23 ビベンティア バイオテック インコーポレイテッド ガン細胞を特異的に検出する抗原結合フラグメント、このフラグメントをコードするヌクレオチド、ならびにガンの予防および検出のためのその使用
US7115722B1 (en) 1997-05-22 2006-10-03 Viventia Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
WO1999006834A2 (en) * 1997-08-04 1999-02-11 Ixsys, Incorporated Methods for identifying ligand specific binding molecules
US7109170B2 (en) * 1999-06-16 2006-09-19 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
AU7262700A (en) * 1999-09-07 2001-04-10 Viventia Biotech Inc. Enhanced phage display library of human vh fragments and methods for producing same
ES2376454T3 (es) * 2000-12-22 2012-03-14 Grad, Carole, Legal Representative Of Howard, Kaplan Librer�?as de expresión en fago de fragmentos vh humanos.
DE10210427A1 (de) * 2002-03-09 2003-10-09 Hans Konrad Mueller-Hermelink Humaner monoklonaler Antikörper
WO2004005351A2 (en) * 2002-07-04 2004-01-15 Oncomab Gmbh Neoplasm specific antibodies and uses thereof
DE10311248A1 (de) 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
NZ577824A (en) * 2003-11-12 2010-10-29 Patrys Ltd Methods of identifying neoplasm-specific antibodies and uses thereof
EP1531162A1 (de) 2003-11-14 2005-05-18 Heinz Vollmers Antikörper SAM-6, der spezifisch von Adenocarzinom ist, und dessen Verwendungen
DE10353175A1 (de) * 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
DE102004015179A1 (de) * 2004-03-25 2005-10-13 Oncomab Gmbh Antigen des PM-2 Antikörpers und dessen Verwendung
CL2007002668A1 (es) * 2006-09-20 2008-05-09 Amgen Inc Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
US8007797B2 (en) 2006-09-28 2011-08-30 Merck Serono S.A. Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use
WO2008152446A2 (en) * 2006-11-27 2008-12-18 Patrys Limited Novel glycosylated peptide target in neoplastic cells
WO2010088739A1 (en) * 2009-02-09 2010-08-12 Patrys Limited Sam-6 variants, target and methods of use
CN103127528B (zh) * 2012-09-14 2016-04-20 苏州大学 人类dcx基因在制备胶质瘤放疗增敏剂中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035088A1 (en) * 1990-01-29 1991-07-30 Michael D. Dan Human monoclonal antibodies for brain tumor diagnosis and therapy

Also Published As

Publication number Publication date
NO965395D0 (no) 1996-12-13
NZ288157A (en) 1999-09-29
AU686394B2 (en) 1998-02-05
NO965395L (no) 1996-12-17
CN1151184A (zh) 1997-06-04
CA2192079A1 (en) 1995-12-28
EP0766736A1 (de) 1997-04-09
US5639863A (en) 1997-06-17
ATE205532T1 (de) 2001-09-15
AU2709295A (en) 1996-01-15
MX9605895A (es) 1997-12-31
EP0766736B1 (de) 2001-09-12
CA2192079C (en) 2001-01-09
CN1074458C (zh) 2001-11-07
JPH10501411A (ja) 1998-02-10
DE69522689T2 (de) 2002-08-08
WO1995035374A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
DE69522689T2 (de) Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper
DE3687736D1 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
DK69890A (da) Monoklonale antistoffer, der er reaktive med cachetin
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
DK0807125T3 (da) Monoklonale antistoffer mod CD6 til behandling og diagnosticering af psoriasis
ZA90982B (en) Cross-linked antibodies
DE69531290D1 (de) Antigen-besierende heteropolymere zur behandlung von autoimmunkrankheiten mittels diesen
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
FI950062A0 (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
DK0749481T3 (da) Humaniserede monoklonale antistoffer mod human interleukin-4
ES8704082A1 (es) Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
ES8502547A1 (es) Un metodo para determinar la presencia de una neoplasia.
EP0166458A3 (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
ATE291620T1 (de) Mammakarzinom-assoziiertes gen
EP0278160A3 (de) Menschliche monoklonale Antikörper gegen Krebs, Hybridoma-Zellinien, die sie herstellen und ihre Anwendungen

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Free format text: ERFINDER IST ANMELDER

8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee